HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage (original) (raw)

• Galvin, J.E., Uryu, K., Lee, V.M. & Trojanowski, J.Q. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc. Natl. Acad. Sci. USA 96, 13450–13455 (1999).
  Article CAS Google Scholar
• Ferguson, B., Matyszak, M.K., Esiri, M.M. & Perry, V.H. Axonal damage in acute multiple sclerosis lesions. Brain 120, 393–399 (1997).
  Article Google Scholar
• Trapp, B.D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278–285 (1998).
  Article CAS Google Scholar
• Dutta, R. & Trapp, B.D. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68, S22–S31; discussion S43–S54 (2007).
  Article Google Scholar
• Trapp, B.D. & Stys, P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 8, 280–291 (2009).
  Article CAS Google Scholar
• Beirowski, B. et al. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci. 6, 6 (2005).
  Article Google Scholar
• Fisher, E. et al. Imaging correlates of axonal swelling in chronic multiple sclerosis brains. Ann. Neurol. 62, 219–228 (2007).
  Article Google Scholar
• Stokin, G.B. et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282–1288 (2005).
  Article CAS Google Scholar
• Watson, D.F., Fittro, K.P., Hoffman, P.N. & Griffin, J.W. Phosphorylation-related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication. Brain Res. 539, 103–109 (1991).
  Article CAS Google Scholar
• Yabe, J.T., Pimenta, A. & Shea, T.B. Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J. Cell Sci. 112, 3799–3814 (1999).
  CAS PubMed Google Scholar
• Pant, H.C. Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem. J. 256, 665–668 (1988).
  Article CAS Google Scholar
• Perez-Olle, R. et al. Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport. J. Neurochem. 93, 861–874 (2005).
  Article CAS Google Scholar
• Kiaei, M. et al. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis. 2, 246–254 (2005).
  Article CAS Google Scholar
• Song, S.K. et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26, 132–140 (2005).
  Article Google Scholar
• Wegner, C., Esiri, M.M., Chance, S.A., Palace, J. & Matthews, P.M. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67, 960–967 (2006).
  Article CAS Google Scholar
• Stone, J.R. et al. Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp. Neurol. 190, 59–69 (2004).
  Article CAS Google Scholar
• Bitsch, A., Schuchardt, J., Bunkowski, S., Kuhlmann, T. & Bruck, W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123, 1174–1183 (2000).
  Article Google Scholar
• King, A.E. et al. Excitotoxicity mediated by non-NMDA receptors causes distal axonopathy in long-term cultured spinal motor neurons. Eur. J. Neurosci. 26, 2151–2159 (2007).
  Article CAS Google Scholar
• Williamson, T.L. & Cleveland, D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2, 50–56 (1999).
  Article CAS Google Scholar
• Adams, J.H., Graham, D.I., Gennarelli, T.A. & Maxwell, W.L. Diffuse axonal injury in non-missile head injury. J. Neurol. Neurosurg. Psychiatry 54, 481–483 (1991).
  Article CAS Google Scholar
• de Ruijter, A.J., van Gennip, A.H., Caron, H.N., Kemp, S. & van Kuilenburg, A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737–749 (2003).
  Article CAS Google Scholar
• Yang, X.J. & Gregoire, S. Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol. Cell. Biol. 25, 2873–2884 (2005).
  Article CAS Google Scholar
• Yao, Y.L., Yang, W.M. & Seto, E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 21, 5979–5991 (2001).
  Article CAS Google Scholar
• Chen, Z. et al. Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells. Cancer Lett. 188, 127–140 (2002).
  Article CAS Google Scholar
• Hubbert, C. et al. HDAC6 is a microtubule-associated deacetylase. Nature 417, 455–458 (2002).
  Article CAS Google Scholar
• Chawla, S., Vanhoutte, P., Arnold, F.J., Huang, C.L. & Bading, H. Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J. Neurochem. 85, 151–159 (2003).
  Article CAS Google Scholar
• Kawaguchi, Y. et al. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727–738 (2003).
  Article CAS Google Scholar
• Dompierre, J.P. et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J. Neurosci. 27, 3571–3583 (2007).
  Article CAS Google Scholar
• Schumacher, P.A., Eubanks, J.H. & Fehlings, M.G. Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury. Neuroscience 91, 733–744 (1999).
  Article CAS Google Scholar
• Pitt, D., Werner, P. & Raine, C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6, 67–70 (2000).
  Article CAS Google Scholar
• Shen, S. et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat. Neurosci. 11, 1024–1034 (2008).
  Article CAS Google Scholar
• Li, J. et al. Inhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelination. J. Neurosci. 28, 6118–6127 (2008).
  Article CAS Google Scholar
• Birgbauer, E., Rao, T.S. & Webb, M. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J. Neurosci. Res. 78, 157–166 (2004).
  Article CAS Google Scholar
• Bruck, W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J. Neurol. 252 (suppl. 5), v3–v9 (2005).
  Article Google Scholar
• Ouardouz, M. et al. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann. Neurol. 65, 160–166 (2009).
  Article CAS Google Scholar
• Kurnellas, M.P., Donahue, K.C. & Elkabes, S. Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers. Biochem. Soc. Trans. 35, 923–926 (2007).
  Article CAS Google Scholar
• Wen, W., Meinkoth, J.L., Tsien, R.Y. & Taylor, S.S. Identification of a signal for rapid export of proteins from the nucleus. Cell 82, 463–473 (1995).
  Article CAS Google Scholar
• Wolff, B., Sanglier, J.J. & Wang, Y. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 4, 139–147 (1997).
  Article CAS Google Scholar
• Uo, T., Veenstra, T.D. & Morrison, R.S. Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms. J. Neurosci. 29, 2824–2832 (2009).
  Article CAS Google Scholar
• Dasmahapatra, G., Almenara, J.A. & Grant, S. Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2. Mol. Pharmacol. 69, 288–298 (2006).
  CAS PubMed Google Scholar
• Morrison, B.E. et al. Neuroprotection by histone deacetylase-related protein. Mol. Cell. Biol. 26, 3550–3564 (2006).
  Article CAS Google Scholar
• Ballas, N. et al. Regulation of neuronal traits by a novel transcriptional complex. Neuron 31, 353–365 (2001).
  Article CAS Google Scholar
• Zhang, Y. et al. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 22, 1168–1179 (2003).
  Article CAS Google Scholar
• Bolger, T.A. & Yao, T.P. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J. Neurosci. 25, 9544–9553 (2005).
  Article CAS Google Scholar
• Hoshino, M. et al. Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein. J. Neurochem. 87, 257–267 (2003).
  Article CAS Google Scholar
• Morfini, G.A. et al. Axonal transport defects in neurodegenerative diseases. J. Neurosci. 29, 12776–12786 (2009).
  Article CAS Google Scholar
• Gu, H., Liang, Y., Mandel, G. & Roizman, B. Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. Proc. Natl. Acad. Sci. USA 102, 7571–7576 (2005).
  Article CAS Google Scholar
• Zhang, Y. & Jones, C. The bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription. J. Virol. 75, 9571–9578 (2001).
  Article CAS Google Scholar
• Viatour, P. et al. Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. J. Biol. Chem. 278, 46541–46548 (2003).
  Article CAS Google Scholar